Oragenics Balance Sheet Health
Financial Health criteria checks 5/6
Oragenics has a total shareholder equity of $3.1M and total debt of $519.4K, which brings its debt-to-equity ratio to 16.9%. Its total assets and total liabilities are $5.2M and $2.1M respectively.
Key information
16.9%
Debt to equity ratio
US$519.39k
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.14m |
| Equity | US$3.08m |
| Total liabilities | US$2.13m |
| Total assets | US$5.20m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OGEN's short term assets ($4.1M) exceed its short term liabilities ($2.1M).
Long Term Liabilities: OGEN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: OGEN has more cash than its total debt.
Reducing Debt: OGEN's debt to equity ratio has increased from 1% to 16.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OGEN has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: OGEN is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.